Department of Obstetrics and Gynecology, Shiga University of Medical Science, Seta Tsukinowa-Cho, Otsu, Shiga, 520-2192, Japan.
NCD Epidemiology Research Center, Shiga University of Medical Science, Otsu, Japan.
Sci Rep. 2022 Sep 12;12(1):15345. doi: 10.1038/s41598-022-19423-x.
We aimed to evaluate the changes in maternal and neonatal complications such as threatened preterm labor (TPL) and preterm birth before and during the coronavirus disease 2019 (COVID-19) pandemic using large-scale real-world data in Japan. We obtained data from the Japan Medical Data Center claims database and evaluated differences in maternal and neonatal complications, such as the prevalence of TPL and preterm birth before the COVID-19 pandemic (in the year 2018 or 2019) and during the COVID-19 pandemic (in 2020). We included 5533, 6257, and 5956 deliveries in the years 2018, 2019, and 2020, respectively. TPL prevalence and preterm birth had significantly decreased in 2020 (41.3%, 2.6%, respectively) compared with those reported in 2018 (45.3%, 3.9%, respectively) and 2019 (44.5%, 3.8%, respectively). Neonatal outcomes such as low-birth-weight infants and retinopathy of prematurity were also improved during the pandemic. There were no clear trends in the prevalence of maternal complications such as hypertensive disorders of pregnancy; hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome; and preeclampsia. Oral ritodrine hydrochloride usage in all participants had significantly decreased during the COVID-19 pandemic. In conclusion, our results suggest that the COVID-19 pandemic has ameliorated TPL and consequently reduced the number of preterm births.
我们旨在使用日本的大规模真实世界数据评估在 2019 年冠状病毒病(COVID-19)大流行前后产妇和新生儿并发症(如先兆早产(TPL)和早产)的变化。我们从日本医疗数据中心索赔数据库中获得数据,并评估了 TPL 发生率和早产等产妇和新生儿并发症在 COVID-19 大流行前(2018 年或 2019 年)和大流行期间(2020 年)的差异。我们分别纳入了 2018 年、2019 年和 2020 年的 5533、6257 和 5956 次分娩。与 2018 年(45.3%,3.9%)和 2019 年(44.5%,3.8%)相比,2020 年 TPL 发生率和早产发生率明显下降(分别为 41.3%和 2.6%)。新生儿结局,如低出生体重儿和早产儿视网膜病变也在大流行期间得到改善。妊娠高血压疾病等产妇并发症的发生率没有明显趋势;溶血性肝酶升高和血小板减少(HELLP)综合征;和子痫前期。在 COVID-19 大流行期间,所有参与者口服盐酸利托君的使用量明显减少。总之,我们的结果表明,COVID-19 大流行改善了 TPL,从而减少了早产的数量。